Multicenter Clinical Evaluation of the (1->3) -D-Glucan Assay as an Aid to Diagnosis of Fungal Infections in Humans
The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI). METHODS: Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects (n = 170) or subjects with proven or probable IFI according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria (n = 163). A central laboratory and 4 sites performed assays. A single sample was obtained per patient and was evaluated using an assay to detect serum BG derived from fungal cell walls (range, 0 to > 7000 pg/mL). RESULTS: At a cutoff of 60 pg/mL, the sensitivity and specificity of the assay were 69.9% and 87.1%, respectively, with a positive predictive value (PPV) of 83.8% and a negative predictive value (NPV) of 75.1%. At a cutoff value of 80 pg/mL, the sensitivity and specificity were 64.4% and 92.4%, respectively, with a PPV of 89% and an NPV of 73%. Of the 107 patients with proven candidiasis, 81.3% had positive results at a cutoff value of 60 pg/mL, and 77.6% had positive results at a cutoff value of 80 pg/mL. Of the 10 patients with aspergillosis, 80% had positive results at cutoff values of 60 and 80 pg/mL. The 3 subjects diagnosed with Fusarium species had positive results at a cutoff value of 60 pg/mL. Patients infected with Mucor or Rhizopus species (both of which lack BG) had negative results at both cutoff values, and of the 12 patients with Cryptococcus infection, 3 had positive results at a cutoff value of 60 pg/mL, and 2 had positive results at a cutoff value of 80 pg/mL. Of the subjects with proven positive results who were receiving antifungal therapy (n = 118), 72.9% had results positive for BG at a cutoff value of 60 pg/mL, and 69.5% had results positive for BG at a cutoff value of 80 pg/mL. The interlaboratory sample test r2 was 0.93. CONCLUSION: Reproducible assay results with high specificity and high PPV in a multicenter setting demonstrate that use of an assay to detect serum BG derived from fungal cell walls is a useful diagnostic adjunct for IFI.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Sensitivity and specificity have been estimated to be 69.9 and 87.1%, respectively [47], as there are a high number of false positive results.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“(1 ?3)-b-D-glucan is a component of the cell wall of many fungi and has been proposed as a non-specific marker for invasive fungal infections.”
From Management of invasive candidiasis and candidemia in adult non-neutropenic intensive care unit patients: part I. Epidemiology and diagnosis (2009) · cites this paper as [47]
In the citing paper
“b-1, 3-D-Glucan detection has also been evaluated in critically ill patients, with sensitivity and specificity for diagnosis of IC estimated to be 69.9% and 87.1%, respectively.63”
From Fungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting (2011) · cites this paper as [63]
Citations
Cites
Ascioglu, S., Rex, J. H., de Pauw, B., Bennett, J. E., Bille, J., Crokaert, F., Denning, D. W., Donnelly, J. P., Edwards, J. E., Erjavec, Z., et al. (2002) · Clinical Infectious Diseases · doi:10.1086/323335 · Cited by 2,331 · cited 3×
“Subjects. Subjects without IFI and subjects with proven or probable IFI (determined according to the European Organization for the Research and Treatment of Cancer/Mycoses Study Group [EORTC/MSG] criteria [ 15 ]) from 6 clinical sites in the United States consented to participate in this study, and a single blood samp…”
MethodSelf-citation(2012) · Hepatogastroenterology · doi:10.5754/hge11801 · Cited by 802
Odabasi, Z., Mattiuzzi, G., Estey, E., Kantarjian, H., Saeki, F., Ridge, R. J., Ketchum, P. A., Finkelman, M. A., Rex, J. H., & Ostrosky-Zeichner, L. (2004) · Clinical Infectious Diseases · doi:10.1086/421944 · Cited by 642 · cited 4×
“The reactivity of the Fungitell assay with Pachyman standard is lower than that of the Fungitec-G assay [9].”
BackgroundMethodSelf-citationObayashi, T., Kawai, T., Yoshida, M., Mori, T., Goto, H., Yasuoka, A., Shimada, K., Iwasaki, H., Teshima, H., Kohno, S., et al. (1995) · The Lancet · doi:10.1016/s0140-6736(95)91152-9 · Cited by 530
Antifungal Susceptibility Survey of 2,000 Bloodstream Candida Isolates in the United States
Ostrosky-Zeichner, L., Rex, J. H., Pappas, P. G., Hamill, R. J., Larsen, R. A., Horowitz, H. W., Powderly, W. G., Hyslop, N., Kauffman, C. A., Cleary, J., et al. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.10.3149-3154.2003 · Cited by 498 · cited 1×
“parapsilosis [19].”
Self-citationThe use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis
Horvath, J. A., & Dummer, S. (1996) · The American Journal of Medicine · doi:10.1016/s0002-9343(97)89455-7 · Cited by 323 · cited 1×
“of cases of invasive aspergillosis [4].”
The New Fungal Opportunists Are Coming
Perfect, J. R., & Schell, W. A. (1996) · Clinical Infectious Diseases · doi:10.1093/clinids/22.supplement_2.s112 · Cited by 224 · cited 1×
“critical care [1].”
Miyazaki, T., Kohno, S., Mitsutake, K., Maesaki, S., Tanaka, K., Ishikawa, N., & Hara, K. (1995) · Journal of Clinical Microbiology · doi:10.1128/jcm.33.12.3115-3118.1995 · Cited by 204
Digby, J., Kalbfleisch, J. H., Glenn, A., Larsen, A. R., Browder, W., & Williams, D. L. (2003) · Clinical and Vaccine Immunology · doi:10.1128/cdli.10.5.882-885.2003 · Cited by 153 · cited 2×
“[18] observed low specificity for fungal infections in a study involving 46 subjects in intensive care units.”
BackgroundMolecular mechanism of hemolymph clotting system in Limulus
Iwanaga, S., Miyata, T., Tokunaga, F., & Muta, T. (1992) · Thrombosis Research · doi:10.1016/0049-3848(92)90124-s · Cited by 133 · cited 1×
“BG produced by fungi [6] is detected by a glucan assay on the basis of its recognition by the innate immune system of horseshoe crabs, specifically Tachypleus tridentatus and Limulus polyphemus [7].”
Background
Research works printed but not linked: 1
- Nakao, 1997, Hepato-gastroenterology, 44, 1413
Cited by
Items 101–200 of 667
β‐1,3 Glucan as a Test for Central Venous Catheter Biofilm Infection
Nett, J., Lincoln, L., Marchillo, K., & Andes, D. (2007) · The Journal of Infectious Diseases · doi:10.1086/517522 · Cited by 93
Non–Culture-Based Diagnostics for Opportunistic Fungi
Mennink‐Kersten, M. A. S. H., & Verweij, P. E. (2006) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2006.06.009 · Cited by 99
(1→3)β-d-Glucan Assay Positivity in Patients with Pneumocystis (carinii) jiroveci Pneumonia
Marty, F. M., Koo, S., Bryar, J., & Baden, L. R. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-1-200707030-00018 · Cited by 91
Enfermedades Infecciosas y Microbiología Clínica
Viasus, D., Antón, A., Pumarola, T., & Carratalà, J. (2016) · Cited by 90
Horn, D. L., Fishman, J. A., Steinbach, W. J., Anaissie, E. J., Marr, K. A., Olyaei, A. J., Pfaller, M. A., Weiss, M. A., Webster, K. M., & Neofytos, D. (2007) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2007.06.008 · Cited by 97
Clinical Utility of Serum .BETA.-D-Glucan and KL-6 Levels in Pneumocystis jirovecii Pneumonia
Nakamura, H., Tateyama, M., Tasato, D., Haranaga, S., Yara, S., Higa, F., Ohtsuki, Y., & Fujita, J. (2009) · Internal Medicine · doi:10.2169/internalmedicine.48.1680 · Cited by 88
Li, S. S., Ogbomo, H., Mansour, M. K., Xiang, R. F., Szabo, L., Munro, F., Mukherjee, P. G., Mariuzza, R. A., Amrein, M., Vyas, J. M., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-03014-4 · Cited by 91
Kedzierska, A. E., Kochan, P., Pietrzyk, A., & Kędzierska, J. (2007) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-007-0373-6 · Cited by 102
“In single serum samples, the level of this marker was lower than 60 pg/mL [45].”
BackgroundMethodMortality and Health Outcomes of HIV-Exposed and Unexposed Children in a PMTCT Cohort in Malawi
Landes, M., van Lettow, M., Chan, A. K., Mayuni, I., Schouten, E. J., & Bedell, R. (2012) · PLoS ONE · doi:10.1371/journal.pone.0047337 · Cited by 86
The Fungal Cell Wall: Structure, Biosynthesis, and Function
Gow, N. A. R., Latge, J.-P., & Munro, C. A. (2017) · The Fungal Kingdom · doi:10.1128/9781555819583.ch12 · Cited by 86
Antifungal stewardship in invasive Candida infections
Ruhnke, M. (2014) · Clinical Microbiology and Infection · doi:10.1111/1469-0691.12622 · Cited by 99
“The test cannot distinguish between infections due to different fungal agents such as Candida, Aspergillus and Pneumocystis jirovecii [19–21].”
BackgroundIntensive care management of influenza-associated pulmonary aspergillosis
Koehler, P., Bassetti, M., Kochanek, M., Shimabukuro-Vornhagen, A., & Cornely, O. A. (2019) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2019.04.031 · Cited by 82
Approach to invasive pulmonary aspergillosis in critically ill patients
Koulenti, D., Garnacho-Montero, J., & Blot, S. (2014) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000043 · Cited by 81
“Its detection provides diagnostic information for IPA in oncohematological patients with neutropenia [43,44].”
BackgroundMaertens, J. A., Theunissen, K., Lodewyck, T., Lagrou, K., & Eldere, J. V. (2007) · Mycoses · doi:10.1111/j.1439-0507.2007.01375.x · Cited by 85
Akamatsu, N., Sugawara, Y., Kaneko, J., Tamura, S., & Makuuchi, M. (2007) · Infection · doi:10.1007/s15010-007-6240-7 · Cited by 81
“Ostrosky-Zeichner et al. [ 34 ] reported in their multicenter study that at a cutoff of 60 pg/ml, the sensitivity and specificity of the BDG assay were 70% and 87%, respectively, and at a cutoff value of 80 pg/ml, the sensitivity and specificity were 64% and 92%, respectively.”
BackgroundAdvances in Antifungal Therapy
Sable, C. A., Strohmaier, K. M., & Chodakewitz, J. A. (2008) · Annual Review of Medicine · doi:10.1146/annurev.med.59.062906.071602 · Cited by 81
Invasive fungal infections in patients with cancer in the Intensive Care Unit
Sipsas, N. V., & Kontoyiannis, D. P. (2012) · International Journal of Antimicrobial Agents · doi:10.1016/j.ijantimicag.2011.11.017 · Cited by 81
Lamoth, F., Akan, H., Andes, D. R., Cruciani, M., Marchetti, O., Ostrosky-Zeichner, L. L., Racil, Z., & Clancy, C. J. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa1943 · Cited by 90
Self-citationSalvatore, C. M., Chen, T. K., Toussi, S. S., DeLaMora, P. A., Petraitienė, R., Finkelman, M., & Walsh, T. J. (2015) · Journal of the Pediatric Infectious Diseases Society · doi:10.1093/jpids/piv014 · Cited by 78
“for diagnosing candidemia and invasive pulmonary aspergillosis, respectively [10–14].”
BackgroundSelf-citationAcosta, J., Catalán, M., del Palacio‐Pérez‐Medel, Á., Lora, D., Montejo, J. C., Cuétara, M. S., Moragues, M. D., Pontón, J., & del Palacio, A. (2010) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2010.03357.x · Cited by 89
Molds: Hyalohyphomycosis, Phaeohyphomycosis, and Zygomycosis
Naggie, S., & Perfect, J. R. (2009) · Clinics in Chest Medicine · doi:10.1016/j.ccm.2009.02.009 · Cited by 84
Scully, E. P., Baden, L. R., & Katz, J. T. (2008) · Current Opinion in Neurology · doi:10.1097/wco.0b013e3282fee95b · Cited by 78
Candidemia and invasive candidiasis: A review of the literature for the burns surgeon
Ha, J. F., Italiano, C. M., Heath, C. H., Shih, S., Rea, S. M., & Wood, F. M. (2010) · Burns · doi:10.1016/j.burns.2010.01.005 · Cited by 97
“4%, respectively; with positive predictive values of 89% and negative predictive values of 73% [4,76,77].”
Mennink-Kersten, M. A. S. H., Ruegebrink, D., Wasei, N., Melchers, W. J. G., & Verweij, P. E. (2006) · Journal of Clinical Microbiology · doi:10.1128/jcm.44.5.1711-1718.2006 · Cited by 76
Rose, S., Vallabhajosyula, S., Velez, M. G., Fedorko, D. P., VanRaden, M. J., Gea‐Banacloche, J., & Lionakis, M. S. (2014) · Journal of Infection · doi:10.1016/j.jinf.2014.04.008 · Cited by 80
“False-positive results have been reported with concurrent bacterial infections (BDG) or antibiotic administration (GM), and false-negative results for both tests have been associated with antifungal prophylaxis.(1,6) The site of testing also seems to play a role as shown by the higher sensitivity of bronchoalveolar la…”
Fungal infections of the central nervous system
Murthy, J. M. K., & Sundaram, C. (2013) · Handbook of clinical neurology · doi:10.1016/b978-0-7020-4088-7.00095-x · Cited by 85
Fusarium Infection in Lung Transplant Patients: Report of 6 Cases and Review of the Literature
Carneiro, H. A., Coleman, J. J., Restrepo, A., & Mylonakis, E. E. (2010) · Medicine · doi:10.1097/md.0b013e318207612d · Cited by 79
“However, this assay cannot distinguish between Fusarium and other fungi.(78,84) A positive BDG test and a negative galactomannan test in a lung transplant patient with a mold infection is highly suggestive of Fusarium infection.”
BackgroundHope, W. W., Petraitis, V., Petraitiene, R., Aghamolla, T., Bacher, J., & Walsh, T. J. (2010) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00673-10 · Cited by 73
“The diagnostic and prognostic value of these biomarkers in experimental models and humans is relatively well characterized (7, 12, 17, 18, 23).”
BackgroundCurrent Status and Future Perspectives on Molecular and Serological Methods in Diagnostic Mycology
Lau, A. F., Chen, W., Sleiman, S., & Sorrell, T. C. (2009) · Future Microbiology · doi:10.2217/fmb.09.70 · Cited by 78
European expert opinion on the management of invasive candidiasis in adults
Kullberg, B. J., Verweij, P. E., Akova, M., Arendrup, M. C., Billé, J., Calandra, T., Cuenca‐Estrella, M., Herbrecht, R., Jacobs, F., Kalin, M., et al. (2011) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2011.03615.x · Cited by 78
“[68,71].”
Self-citationPazos, C., Moragues, M. D., Quindós, G., Pontón, J., & del Palacio, A. (2006) · Revista Iberoamericana de Micología · doi:10.1016/s1130-1406(06)70046-8 · Cited by 73
Reactivity of (1 → 3)-β-d-glucan assay in bacterial bloodstream infections
Albert, O., Toubas, D., Strady, C., Cousson, J., Delmas, C., Vernet, V., & Villena, I. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1244-8 · Cited by 71
Application of the 1,3-β-d-Glucan (Fungitell) Assay in the Diagnosis of Invasive Fungal Infections
Tran, T. Q., & Beal, S. G. (2016) · Archives of Pathology & Laboratory Medicine · doi:10.5858/arpa.2014-0230-rs · Cited by 77
New Concepts in Diagnostics for Invasive Mycoses: Non-Culture-Based Methodologies
Patterson, T. F., & Donnelly, J. P. (2019) · Journal of Fungi · doi:10.3390/jof5010009 · Cited by 74
“with acute leukemia, which allowed regulatory clearance as well as inclusion in the European Organization for Research and Treatment of Cancer/Mycoses Study Group (EORTC-MSG) definitions for fungal infection [33,34].”
Springer, J., Lackner, M., Nachbaur, D., Girschikofsky, M., Risslegger, B., Mutschlechner, W., Fritz, J., Heinz, W., Einsele, H., Ullmann, A. J., et al. (2015) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2015.09.009 · Cited by 71
Lewis, R. E., Liao, G., Hou, J., Chamilos, G., Prince, R. A., & Kontoyiannis, D. P. (2007) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.01449-06 · Cited by 69
“1% in patients with proven 10 infections when the 60 pg/mL cutoff value is used to define sample positivity (23).”
MethodIncreased incidence of interstitial pneumonia by CHOP combined with rituximab
Ennishi, D., Terui, Y., Yokoyama, M., Mishima, Y. M., Takahashi, S., Takeuchi, K., Ikeda, K., Tanimoto, M., & Hatake, K. (2008) · International Journal of Hematology · doi:10.1007/s12185-008-0066-7 · Cited by 69
Theel, E. S., Jespersen, D. J., Iqbal, S., Bestrom, J. E., Rollins, L. O., Misner, L., Markley, B., Mandrekar, J. N., Baddour, L. M., LIMPER, A. H., et al. (2012) · Mycopathologia · doi:10.1007/s11046-012-9579-y · Cited by 72
“Previous studies of ICH patients indicate that the sensitivity and specificity of the Fungitell assay for documenting invasive fungal infections performed on serum specimens ranges from 64–93 % and 87–100 %, respectively, depending on the positive cutoff value used in the respective study [3, 5, 18, 19].”
MethodUpdate on the epidemiology and diagnosis of invasive fungal infection
Cuenca‐Estrella, M., Bernal‐Martínez, L., Buitrago, M. J., Castelli, M. V., Gómez‐López, A., Zaragoza, Ó., & Rodríguez-Tudela, J. L. (2008) · International Journal of Antimicrobial Agents · doi:10.1016/s0924-8579(08)70016-5 · Cited by 76
“Therefore, in a recently published study including more than 100 patients with candidiasis, sensitivity was 82% with a positive predictive value (PPV) close to 90%, bringing the diagnosis of infection forward by 7 days [31].”
BackgroundInvasive candidiasis: A review of nonculture-based laboratory diagnostic methods
Ahmad, S., & Khan, Z. (2012) · Indian Journal of Medical Microbiology · doi:10.4103/0255-0857.99482 · Cited by 67
Wingard, J. R., Hiemenz, J. W., & Jantz, M. A. (2012) · Blood · doi:10.1182/blood-2012-02-378976 · Cited by 69
Self-citationDiagnosing invasive fungal disease in critically ill patients
Hsu, J. L., Ruoss, S. J., Bower, N. D., Lin, M., Holodniy, M., & Stevens, D. A. (2011) · Critical Reviews in Microbiology · doi:10.3109/1040841x.2011.581223 · Cited by 79
“Likewise, in a multicenter study, the BG assay (Fungitell) at a cut-off value of 80 pg/ml had a sensitivity of 64% and a specificity of 92% for detection of multiple Candida, Aspergillus, and Fusarium species (Ostrosky-Zeichner et al., 2005).”
BackgroundMorris, A., Hillenbrand, M. E., Finkelman, M., George, M. P., Singh, V. K., Kessinger, C. J., Lucht, L. A., Busch, M. A., McMahon, D. K., Weinman, R., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318271799b · Cited by 68
Self-citationProspective Evaluation of Serum β-Glucan Testing in Patients With Probable or Proven Fungal Diseases
Angebault, C., Lanternier, F., Dalle, F., Schrimpf, C., Roupie, A.-L., Dupuis, A., Agathine, A., Scemla, A., Paubelle, E., Caillot, D., et al. (2016) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofw128 · Cited by 66
Consensus on the treatment of second-degree burn wounds (2024 edition)
Ji, S., Xiao, S., & Xia, Z. (2024) · Burns & Trauma · doi:10.1093/burnst/tkad061 · Cited by 93
“…such as PCR and NGS have higher sensitivity and reproducibility in detecting fungal DNA; furthermore, they are rapid and efficient, thus providing better evidence that supports early clinical diagnosis and compensates for the long detection time needed for routine fungal culture [276, 277].”
BackgroundKoo, S., Baden, L. R., & Marty, F. M. (2012) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2012.03777.x · Cited by 64
van Hal, S. J., Marriott, D. J. E., Chen, S. C.-A., Nguyen, Q. A., Sorrell, T. C., Ellis, D. H., Slavin, M. A., & Study, T. A. C. (2009) · Transplant Infectious Disease · doi:10.1111/j.1399-3062.2009.00371.x · Cited by 65
Measurement of (1-3)-.BETA.-D-Glucan Derived from Different Gauze Types
Kanamori, H., Kanemitsu, K., Miyasaka, T., Ameku, K., Endo, S., Aoyagi, T., Inden, K., Hatta, M., Yamamoto, N., Kunishima, H., et al. (2009) · The Tohoku Journal of Experimental Medicine · doi:10.1620/tjem.217.117 · Cited by 63
“The clinical utility of BDG detection has also been reported outside of Japan (Odabasi et al. 2004; Ostrosky-Zeichner et al. 2005; Pickering et al. 2005).”
BackgroundMethodInfluentialSendid, B., Dotan, N., Nseir, S., Savaux, C., Vandewalle, P., Standaert, A., Zerimech, F., Guery, B. P., Dukler, A., Colombel, J. F., et al. (2008) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00200-08 · Cited by 63
“In clinical circumstances, sensitive detection assays have demonstrated that the presence of circulating glucans in patients’ sera is indicative of fungal invasion (27), and studies suggest that glucan could be a valuable marker of fungal infection (50).”
BackgroundFungal Sepsis: Optimizing Antifungal Therapy in the Critical Care Setting
Lepak, A., & Andes, D. (2011) · Critical Care Clinics · doi:10.1016/j.ccc.2010.11.001 · Cited by 62
Improving the management of candidemia through antimicrobial stewardship interventions
Reed, E. E., West, J. E., Keating, E. A., Pancholi, P., Balada-Llasat, J.-M., Mangino, J. E., Bauer, K. A. A., & Goff, D. A. (2013) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2013.11.012 · Cited by 66
“Examples of tests that can be performed directly from blood or plasma include: (1-3)-β-D-glucan assay (from plasma), polymerase chain reaction (PCR) (from blood culture), and matrix assisted laser desorption ionization–time-offlight mass spectrometry (MALDI-TOF) (from blood culture or a yeast colony following growth o…”
MethodPetraitienė, R., Petraitis, V., Hope, W. W., Mickiene, D., Kelaher, A. M., Murray, H. A., Mya-San, C., Hughes, J. E., Cotton, M. P., Bacher, J. D., et al. (2008) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.00674-08 · Cited by 66
“Detection of -glucan is possible using a colorimetric assay read at 405 nm, based upon para-nitroanilide absorption at that wavelength (26, 28, 32).”
BackgroundMethodDe Vlieger, G., Lagrou, K., Maertens, J., Verbeken, E., Meersseman, W., & Van Wijngaerden, E. (2011) · Journal of Clinical Microbiology · doi:10.1128/jcm.00879-11 · Cited by 62
“They found a sensitivity of 70% and a specificity of 87% to detect IFI at a cutoff of 60 pg/ml (20).”
BackgroundBandara, N., & Samaranayake, L. P. (2019) · Periodontology 2000 · doi:10.1111/prd.12273 · Cited by 74
Bloos, F., Held, J., Kluge, S., Simon, P., Kogelmann, K., de Heer, G., Kuhn, S., Jarczak, D., Motsch, J., Hempel, G., et al. (2022) · Intensive Care Medicine · doi:10.1007/s00134-022-06733-x · Cited by 66
“intraabdominal candidiasis [8, 39, 40], a higher cut-off such as 200 pg/mL has been suggested to increase specificity [41].”
BackgroundCuétara, M. S., Alhambra, A., Moragues, M. D., González-Elorza, E., Pontón, J., & del Palacio, A. (2009) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00009-09 · Cited by 62
“Different studies have established its diagnostic value in invasive candidiasis and invasive aspergillosis (9, 10).”
BackgroundResultDisseminated Human Conidiobolomycosis Due to Conidiobolus lamprauges
Kimura, M., Yaguchi, T., Sutton, D. A., Fothergill, A. W., Thompson, E. H. Z., & Wickes, B. L. (2010) · Journal of Clinical Microbiology · doi:10.1128/jcm.01484-10 · Cited by 61
“Since the zygomycetes and Cryptococcus species have lower BG content, BG detection assays are often less useful (9).”
BackgroundCurrent diagnostic approaches to invasive candidiasis in critical care settings
Pemán, J., & Zaragoza, R. (2010) · Mycoses · doi:10.1111/j.1439-0507.2009.01732.x · Cited by 68
Serum (1→3)-β- d -Glucan Measurement in Coccidioidomycosis
Thompson, G. R., Bays, D. J., Johnson, S. M., Cohen, S. H., Pappagianis, D., & Finkelman, M. (2012) · Journal of Clinical Microbiology · doi:10.1128/jcm.00631-12 · Cited by 60
Self-citationDel Bono, V., Delfino, E., Furfaro, E., Mikulska, M., Nicco, E., Bruzzi, P., Mularoni, A., Bassetti, M., & Viscoli, C. (2011) · Clinical and Vaccine Immunology · doi:10.1128/cvi.05408-11 · Cited by 58
“As an alternative to blood culture, neither antigen detection nor molecular techniques are fully reliable in diagnosing candidemia (4), although the detection of (1,3)- -D-glucan (BG), a component of the cell walls of several fungal species, has been reported to be a potentially useful aid for diagnosis of invasive fu…”
BackgroundResultBench-to-bedside review: Therapeutic management of invasive candidiasis in the intensive care unit
Bassetti, M., Mikulska, M., & Viscoli, C. (2010) · Critical Care · doi:10.1186/cc9239 · Cited by 57
“In particular, β-d-glucan is a component of the cell wall of Candida and other fungi and has been investigated as a serological marker for fungal infections, including candidemia [ 61 ].”
Background(1–3)-β-D-Glucan Assay: A Review of its Laboratory and Clinical Application
Wright, W. F., Overman, S. B., & Ribes, J. A. (2011) · Laboratory Medicine · doi:10.1309/lm8bw8qnv7nzbrog · Cited by 66
Azoulay, E., Guigue, N., Darmon, M., Mokart, D., Lemiale, V., Kouatchet, A., Mayaux, J., Vincent, F., Nyunga, M., Bruneel, F., et al. (2016) · Oncotarget · doi:10.18632/oncotarget.7471 · Cited by 56
Fungal Infections of the Stem Cell Transplant Recipient and Hematologic Malignancy Patients
Bays, D. J., & Thompson, G. R. (2019) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2019.02.006 · Cited by 61
Candida Peritonitis: An Update on the Latest Research and Treatments
Carneiro, H. A., Mavrakis, A., & Mylonakis, E. E. (2011) · World Journal of Surgery · doi:10.1007/s00268-011-1305-2 · Cited by 59
Presterl, E., Parschalk, B., Bauer, E., Lassnigg, A., Hajdu, S., & Graninger, W. (2009) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2008.10.013 · Cited by 53
Lyons, J. L., Thakur, K. T., Lee, R., Watkins, T., Pardo, C. A., Carson, K. A., Markley, B., Finkelman, M., Marr, K. A., Roos, K. L., et al. (2014) · Journal of Clinical Microbiology · doi:10.1128/jcm.02301-14 · Cited by 54
Self-citationDiagnosis and Treatment of Candidemia in the Intensive Care Unit
Bassetti, M., Giacobbe, D. R., Vena, A., & Wolff, M. (2019) · Seminars in Respiratory and Critical Care Medicine · doi:10.1055/s-0039-1693704 · Cited by 72
Shariati, A., Moradabadi, A., Chegini, Z., Khoshbayan, A., & Didehdar, M. (2020) · Infection and Drug Resistance · doi:10.2147/idr.s254478 · Cited by 64
Tamura, H., Reich, J., & Nagaoka, I. (2021) · Biomedicines · doi:10.3390/biomedicines9050536 · Cited by 63
Self-citationInvasive Fungal Infections in the ICU
Shoham, S., & Marwaha, S. (2009) · Journal of Intensive Care Medicine · doi:10.1177/0885066609355262 · Cited by 63
Begier, E. M., Oberste, M. S., Landry, M. L., Brennan, T. P., Mlynarski, D., Mshar, P., Frenette, K., Rabatsky‐Ehr, T., Purviance, K., Nepaul, A., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/590562 · Cited by 54
Airway and parenchymal manifestations of pulmonary aspergillosis
Tunnicliffe, G., Schomberg, L. E., Walsh, S. L. F., Tinwell, B., Harrison, T., & Chua, F. (2013) · Respiratory Medicine · doi:10.1016/j.rmed.2013.03.016 · Cited by 59
Defining the diagnosis of invasive aspergillosis
Chamilos, G., & Kontoyiannis, D. P. (2006) · Medical Mycology · doi:10.1080/13693780600823258 · Cited by 51
Surgical critical care: Fungal infections in surgical patients
Lipsett, P. A. (2006) · Critical Care Medicine · doi:10.1097/01.ccm.0000231883.93001.e0 · Cited by 52
Einsele, H., & Loeffler, J. (2008) · Clinical Microbiology and Infection · doi:10.1111/j.1469-0691.2008.01980.x · Cited by 48
Opportunistic Fungi: A View to the Future
Pappas, P. G. (2010) · The American Journal of the Medical Sciences · doi:10.1097/maj.0b013e3181e99c88 · Cited by 58
Self-citationthe study group Candida albicans Germ Tube Antibody Detection in Critically Ill Patients (CAGTAUCI), Pemán, J., Zaragoza, R., Quindós, G., Alkorta, M., Cuétara, M. S., Camarena, J. J., Ramírez, P., Giménez, M. J., Martín‐Mazuelos, E., et al. (2011) · BMC Infectious Diseases · doi:10.1186/1471-2334-11-60 · Cited by 55
“New scores and laboratory tests have been developed in order to make an early therapeutic intervention in an attempt to reduce the high mortality associated with invasive fungal infections [12,13].”
BackgroundHigh Levels of β- d -Glucan in Immunocompromised Children with Proven Invasive Fungal Disease
Mularoni, A., Furfaro, E., Faraci, M., Franceschi, A., Mezzano, P., Bandettini, R., Viscoli, C., & Castagnola, E. (2010) · Clinical and Vaccine Immunology · doi:10.1128/cvi.00038-10 · Cited by 50
“In spite of the use of different diagnostic assays, studies in neutropenic and nonneutropenic adults demonstrated that the monitoring of BDG levels might be a useful noninvasive method for the early diagnosis of IFD (6, 10, 11, 13, 14).”
MethodAngioinvasive fungal infections impacting the skin
Berger, A. P., Ford, B. A., Brown‐Joel, Z. O., Shields, B. E., Rosenbach, M. A., & Wanat, K. A. (2018) · Journal of the American Academy of Dermatology · doi:10.1016/j.jaad.2018.04.058 · Cited by 51
Pető, Z., Benkő, R., Matúz, M., Csüllög, E., Molnar, A., & Hajdú, E. (2008) · Infection · doi:10.1007/s15010-008-7377-8 · Cited by 52
Girouard, G., Lachance, C., & Pelletier, R. (2007) · Journal of Medical Microbiology · doi:10.1099/jmm.0.47162-0 · Cited by 49
Kikkert, R., Bulder, I., de Groot, E. R., Aarden, L. A., & Finkelman, M. (2007) · Journal of Endotoxin Research · doi:10.1177/0968051907080024 · Cited by 47
“Therefore, we continued our experiments with a (1→3)-β-D-glucan-rich extract from menstrual tampons and a purified (1→3)-β-D-glucan, pachyman,(33) that is used as (1→3)-β-D-glucan standard in an alternative LAL assay (Fungitell®, Associates of Cape Cod, East Falmouth, MA, USA) which specifically measures (1→3)-β-D-glu…”
MethodSelf-citationDetection of High Cerebrospinal Fluid Levels of (1→3)-β-d-Glucan in Cryptococcal Meningitis
Rhein, J., Bahr, N. C., Morawski, B. M., Schutz, C., Zhang, Y., Finkelman, M., Meya, D. B., Meintjes, G., & Boulware, D. R. (2014) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofu105 · Cited by 48
“Previous studies on the utility of BDG in cryptococcal disease have focused on the detection of BDG in serum, with variable performance reported [8–11, 19, 20].”
Self-citationLyons, J. L., Roos, K. L., Marr, K. A., Neumann, H. J., Trivedi, J. B., Kimbrough, D. J., Steiner, L., Thakur, K. T., Harrison, D. M., & Zhang, S. X. (2013) · Journal of Clinical Microbiology · doi:10.1128/jcm.00061-13 · Cited by 48
Clinical characteristics and risk factors of ocular candidiasis
Nagao, M., Saito, T., Doi, S., Hotta, G., Yamamoto, M., Matsumura, Y., Matsushima, A., Ito, Y., Takakura, S., & Ichiyama, S. (2012) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/j.diagmicrobio.2012.03.006 · Cited by 51
Poissy, J., Sendid, B., Damiens, S., Ishibashi, K. I., François, N., Kauv, M., Favory, R., Mathieu, D., & Poulain, D. (2014) · Critical Care · doi:10.1186/cc13953 · Cited by 50
Emerging Fungal Infections in Solid Organ Transplant Recipients
Shoham, S. (2013) · Infectious Disease Clinics of North America · doi:10.1016/j.idc.2013.02.004 · Cited by 50
Aspergillus Infections in the Critically Ill
Dutkiewicz, R., & Hage, C. A. (2010) · Proceedings of the American Thoracic Society · doi:10.1513/pats.200906-050al · Cited by 50
“Detection of (1/ 3)-b-D-glucan antigen has also been used as a diagnostic aid for IA (42), but the assay lacks specificity, as this antigen is present in many other fungi (43) and is commonly detected in ICU patients without any evidence of invasive fungal infection (44).”
MethodMikulska, M., Furfaro, E., Del Bono, V., Raiola, A. M., Di Grazia, C., Bacigalupo, A., & Viscoli, C. (2013) · Clinical Infectious Diseases · doi:10.1093/cid/cit073 · Cited by 46
Ambasta, A., Carson, J. A., & Church, D. L. (2015) · Medical Mycology · doi:10.1093/mmy/myv026 · Cited by 48
“The assay is not specific to Aspergillus and can be positive in other fungal infections including Candida and Pneumocystis jirovecii infections [154,163–165].”
BackgroundPoulain, D., Sendid, B., Standaert‐Vitse, A., Fradin, C., Jouault, T., Jawhara, S., & Colombel, J. (2009) · Digestive Diseases · doi:10.1159/000268129 · Cited by 51
Yoshida, K., Shoji, H., Takuma, T., & Niki, Y. (2011) · Journal of Infection and Chemotherapy · doi:10.1007/s10156-010-0198-6 · Cited by 45
“Although Ostrosky-Zeichner et al. [ 8 ] showed that the sensitivity, specificity, PPV, and NPV of the Fungitell kit varied with different cut-off values, patients with Mucor spp., Rhizopus spp., or Cryptococcus spp.”
BackgroundJenks, J. D., Gangneux, J.-P., Schwartz, I. S., Alastruey-Izquierdo, A., Lagrou, K., Thompson III, G. R., Lass-Flörl, C., Hoenigl, M., & Investigators, E. C. O. M. M. (. C. (2020) · Journal of Fungi · doi:10.3390/jof6040216 · Cited by 44
Acosta, J., Catalán, M., del Palacio‐Pérez‐Medel, Á., Montejo, J. C., de la Cruz, J., Moragues, M. D., Pontón, J., Finkelman, M., & del Palacio, A. (2011) · European Journal of Clinical Microbiology & Infectious Diseases · doi:10.1007/s10096-011-1365-0 · Cited by 48
“BG assay was first introduced in Japan almost two decades ago [9, 20].”
BackgroundMethodResultInfluentialSelf-citationNonmolecular Methods for the Diagnosis of Respiratory Fungal Infections
Lamoth, F., & Alexander, B. D. (2014) · Clinics in Laboratory Medicine · doi:10.1016/j.cll.2014.02.006 · Cited by 54
Self-citationThe pathogenicity of Aspergillus fumigatus, drug resistance, and nanoparticle delivery
Szalewski, D. A., Hinrichs, V. S., Zinniel, D. K., & Barletta, R. G. (2018) · Canadian Journal of Microbiology · doi:10.1139/cjm-2017-0749 · Cited by 52
“Several -1,3- D-glucan commercial kits are available: Fungitell® (Associates of Cape Code), Wako® (Wako Pure Chemical Industries), Fungitec-G (Seikagaku Kogyo), and B-G Star (Maruha) (Kawazu et al. 2004; Ostrosky-Zeichner et al. 2005; Hachem et al. 2009; Theel and Doern 2013).”
Gallien, S., Fournier, S., Porcher, R., Bottero, J., Ribaud, P., Sulahian, A., Socié, G., & Molina, J. (2008) · Infection · doi:10.1007/s15010-008-7375-x · Cited by 48
“Also, new tests and new strategies have been developed to allow an early diagnosis of IA in patients at risk [6–10], thus contributing to a more favorable response to therapy [9].”
MethodMutschlechner, W., Risslegger, B., Willinger, B., Hoenigl, M., Bucher, B., Eschertzhuber, S., & Lass‐Flörl, C. (2015) · Transplantation · doi:10.1097/tp.0000000000000635 · Cited by 46
Lahmer, T., Neuenhahn, M., Held, J., Rasch, S., Schmid, R. M., & Huber, W. (2016) · Journal of Critical Care · doi:10.1016/j.jcrc.2016.06.026 · Cited by 48
Metadata
- Authors
- Ostrosky-Zeichner, L., Alexander, B. D., Kett, D. H., Vazquez, J., Pappas, P. G., Saeki, F., Ketchum, P. A., Wingard, J., Schiff, R., Tamura, H., Finkelman, M. A., & Rex, J. H.
- Affiliations
- Duke University (US)
- University of Miami (US)
- University of Alabama at Birmingham (US)
- Seikagaku Corporation (Japan) (JP)
- University of Florida Health (US)
- College of Idaho (US)
- AstraZeneca (United Kingdom) (GB)
- Venue
- Clinical Infectious Diseases
- Publisher
- Oxford University Press (OUP)
- Published
- 2005-09-01
- Volume
- 41
- Issue
- 5
- Pages
- 654-659
- ISSN
- 1058-4838 (ISSN-L)
- 1537-6591
- OpenAlex
- W2127508258
- Cited by
- 669
- References
- 26
- Citations by year
- 2026: 8 · 2025: 16 · 2024: 12 · 2023: 14 · 2022: 7 · 2021: 15 · 2020: 16 · 2019: 25 · 2018: 25 · 2017: 21 · 2016: 38 · 2015: 29 · 2014: 50 · 2013: 42 · 2012: 39
- FWCI
- 29.11
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Clinical Infectious Diseases (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Infectious Diseases › Antifungal resistance and susceptibility
- Health Sciences › Medicine › Infectious Diseases › Fungal Infections and Studies
- Life Sciences › Immunology and Microbiology › Immunology › Immunodeficiency and Autoimmune Disorders
- Keywords
- β-1,3-glucan, invasive fungal infections, fungal infection diagnosis, candidiasis, aspergillosis, Fusarium, Mucor, Rhizopus, Cryptococcus, antifungal therapy, sensitivity and specificity, cut-off values, interlaboratory agreement, serum biomarkers, EORTC/MSG criteria
- MeSH terms
- Adult, Aged, Female, Humans, Male, Middle Aged, Mycoses, Proteoglycans, Sensitivity and Specificity, Reproducibility of Results, beta-Glucans
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.